<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Renal Inj Prev</journal-id><journal-id journal-id-type="iso-abbrev">J Renal Inj Prev</journal-id><journal-id journal-id-type="publisher-id">J Renal Inj Prev</journal-id><journal-id journal-id-type="publisher-id">JRIP</journal-id><journal-title-group><journal-title>Journal of Renal Injury Prevention</journal-title></journal-title-group><issn pub-type="epub">2345-2781</issn><publisher><publisher-name>Nickan Research Institute</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25340161</article-id><article-id pub-id-type="pmc">4206038</article-id><article-id pub-id-type="doi">10.12861/jrip.2014.10</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Efficacy of supplementary vitamin D on improvement of glycemic parameters in patients with type 2 diabetes mellitus; a randomized double blind clinical trial</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Nasri</surname><given-names>Hamid</given-names></name><xref ref-type="aff" rid="A01">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Behradmanesh</surname><given-names>Saeed</given-names></name><xref ref-type="aff" rid="A02">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Maghsoudi</surname><given-names>Ahmad Reza</given-names></name><xref ref-type="aff" rid="A02">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ahmadi</surname><given-names>Ali</given-names></name><xref ref-type="aff" rid="A03">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Nasri</surname><given-names>Parto</given-names></name><xref ref-type="aff" rid="A04">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Rafieian-Kopaei</surname><given-names>Mahmoud</given-names></name><xref ref-type="aff" rid="A05">
<sup>5</sup>
</xref><xref rid="COR1" ref-type="corresp">*</xref></contrib></contrib-group><aff id="A01"><sup>1</sup>Department of Nephrology, Division of Nephropathology, Isfahan University of Medical Sciences, Isfahan, Iran
</aff><aff id="A02"><sup>2</sup>Department of Internal Medicine, Shahrekord University of Medical Sciences, Shahrekord, Iran
</aff><aff id="A03"><sup>3</sup>Department of Epidemiology, Shahid Beheshti University of Medical Sciences, Tehran, Iran
</aff><aff id="A04"><sup>4</sup>Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
</aff><aff id="A05"><sup>5</sup>Medical Plants Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran
</aff><author-notes><corresp id="COR1"><label>*</label><bold>Corresponding author:</bold> Prof. Mahmoud Rafieian-kopaei, Medical Plants Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran <email>rafieian@yahoo.com</email></corresp></author-notes><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>30</day><month>11</month><year>2013</year></pub-date><volume>3</volume><issue>1</issue><fpage>31</fpage><lpage>34</lpage><history><date date-type="received"><day>10</day><month>8</month><year>2013</year></date><date date-type="accepted"><day>15</day><month>9</month><year>2013</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2014 The Author(s); Published by Nickan Research Institute</copyright-statement><copyright-year>2014</copyright-year><license xlink:href="http://creativecommons.org/licenses/by/4.0/" license-type="open-access"><license-p><!--CREATIVE COMMONS-->
This is an open-access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
</license-p></license></permissions><self-uri xlink:href="http://journalrip.com">http://journalrip.com</self-uri><abstract><p>
<bold>Introduction: </bold> Studies have revealed the association between vitamin D deficiency and changes in blood glucose and insulin levels as well as sensitivity of the target tissues to insulin.
</p><p>
<bold>Objective:</bold> In this study, we examined the effect of adding vitamin D (cholecalciferol ; 50,000 units) to therapeutic regimen of T2DM patients compared to placebo on regulating the blood glucose and glycemic parameters.
</p><p>
<bold> Patients and Methods:</bold> This study was a double blind clinical trial conducted on 60 type 2 diabetes mellitus (T2DM) patients. Exclusion criteria were taking calcium, vitamin D supplements or any drugs effecting calcium and vitamin D metabolism in the past 6 months. Serum 25-Hydroxy vitamin D [25(OH)D] level was measured with ELISA method. Patients were administered weekly vitamin D supplementation (50000 units) for 12 weeks.
</p><p>
<bold>Results:</bold> There was no significant relation between HbA1c and 25(OH)D level prior the study (p&#x0003e; 0.05). After intervention, 25(OH)D level in interventional group was significantly higher compared to that of control group. HbA1c in male interventional group was significantly less than that of control group (p= 0.0068).
</p><p>
<bold>Conclusion:</bold> Weekly vitamin D supplementation had beneficial effect on glycemic parameters in male type 2 diabetic patients.
</p></abstract><kwd-group><kwd>Type 2 diabetes patients</kwd><kwd>Vitamin D</kwd><kwd>HbA1c</kwd></kwd-group><counts><table-count count="1"/><ref-count count="25"/><page-count count="4"/></counts></article-meta><notes><p>
<italic>Please cite this paper as:</italic> Nasri H, Behradmanesh S, Maghsoudi AR, Ahmadi A, Nasri P, Rafieian-Kopaei M. Efficacy of supplementary vitamin D on improvement of glycemic parameters in patients with type 2 diabetes mellitus; a randomized double blind clinical trial. J Renal Inj Prev 2014; 3(1):31-34. DOI: 10.12861/jrip.2014.10
</p></notes></front><body><boxed-text position="float" id="bt1" orientation="portrait"><sec id="key1"><title>Implication for health policy/practice/research/medical education:</title><p>
In this study we found that weekly vitamin D supplementation (cholecalciferol; 50,000 units for 12 weeks) had beneficial effect on HbA1c of male type 2 diabetic patients. Thus, oral vitamin D may help in improvement of glycemic control in these patients.
</p></sec></boxed-text><sec id="s1"><title>
Introduction
</title><p>
Diabetes mellitus is one of the most common metabolic diseases in the whole world. Over 150 million people are diagnosed with this disease worldwide and it is predicted that this number will reach to over 300 million people by 2025 (<xref rid="R01" ref-type="bibr">1</xref>). Vitamin D is a fat soluble vitamin which was discovered and named calciferol in 1930. In fact this vitamin is a hormonal precursor which its end product is built up inside the body (<xref rid="R01" ref-type="bibr">1</xref>,<xref rid="R02" ref-type="bibr">2</xref>). Apart from the crucial role of this vitamin in bones, this vitamin plays an essential role in autoimmune disorders as well as preventing colorectal, breast and prostatic cancer through preventing cell proliferation (<xref rid="R03" ref-type="bibr">3</xref>). Although 1,25(OH)2 vitamin D3 is important in calcium homeostasis, several investigations have revealed the effect of this vitamin on function of the immune system and also type 1 and type 2 diabetes mellitus (T2DM) (<xref rid="R04" ref-type="bibr">4</xref>). Studies have revealed the association between vitamin D deficiency and changes in blood glucose and insulin levels as well as sensitivity of the target tissues to insulin (<xref rid="R05" ref-type="bibr">5</xref>,<xref rid="R06" ref-type="bibr">6</xref>). This vitamin has many functions in the body and its receptors are present in over 30 different tissues such as pancreas, heart and lymphocytes (<xref rid="R04" ref-type="bibr">4</xref>-<xref rid="R06" ref-type="bibr">6</xref>). Vitamin D might help controlling diabetes mellitus through increasing insulin secretions and increasing sensitivity to this hormone (<xref rid="R04" ref-type="bibr">4</xref>-<xref rid="R06" ref-type="bibr">6</xref>). Several researches have evaluated the association between vitamin D deficiency and glucose intolerance prevalence of T2DM. Various studies have shown a negative association between serum vitamin D level and glucose intolerance, while some others have not found any correlation (<xref rid="R07" ref-type="bibr">7</xref>). Only a few studies have assessed the effect of vitamin D on changes in blood glucose levels and insulin sensitivity, reporting controversial results (<xref rid="R07" ref-type="bibr">7</xref>-<xref rid="R10" ref-type="bibr">10</xref>). Many studies have demonstrated positive effect of vitamin D supplements on controlling hyperglycemia in diabetic patients. However, these studies are mainly conducted on animals (<xref rid="R08" ref-type="bibr">8</xref>-<xref rid="R11" ref-type="bibr">11</xref>). Studies on rats have revealed the direct effect of vitamin D on insulin secretion (<xref rid="R06" ref-type="bibr">6</xref>-<xref rid="R12" ref-type="bibr">12</xref>). Yet, the results of precisely designed randomized double blind controlled trials are not consistent with this finding (<xref rid="R10" ref-type="bibr">10</xref>-<xref rid="R13" ref-type="bibr">13</xref>).
</p><p>
Various studies have demonstrated the presence of 1-&#x003b1; hydroxylase and vitamin D receptors (VDR) on beta cells of pancreas. This enzyme converts 25(OH)D to 1, 25(OH)2 D3 (<xref rid="R07" ref-type="bibr">7</xref>-<xref rid="R13" ref-type="bibr">13</xref>). These findings suggest the possible effect of vitamin D on glucose homeostasis (<xref rid="R10" ref-type="bibr">10</xref>-<xref rid="R16" ref-type="bibr">16</xref>). Therefore, if the beneficial effect of vitamin D therapy on controlling diabetes is approved, it could be used as an adjunct therapy in treating diabetes. Furthermore, it is revealed that vitamin D deficiency, even in developed countries is more than what predicted (<xref rid="R12" ref-type="bibr">12</xref>-<xref rid="R17" ref-type="bibr">17</xref>).
</p></sec><sec id="s2"><title>
Objectives
</title><p>
In this study, we examined the effect of adding vitamin D to therapeutic regimen of T2DM patients compared to placebo on regulating the blood glucose and glycemic parameters.
</p></sec><sec id="s3"><title>
Method and Materials
</title><sec id="s3-1"><title>
Patients
</title><p>
This study was a randomized, double-blind, placebo controlled clinical trial on 60 patients diagnosed with T2DM referred to endocrinology clinic of Shahrekord University of Medical Sciences in 2011. The patients by computer-generated randomly permutated codes (prepared by WHO/Geneva) were allocated into two equal groups of 30. The inclusion criteria were definite diagnosis of T2DM according to standard criteria, no renal or hepatic disease or any other chronic illness based on history and physical examinations. Exclusion criteria were taking calcium, vitamin D supplements or any drugs effecting calcium and vitamin D metabolism in the past 6 months.
</p></sec><sec id="s3-2"><title>
Laboratory tests
</title><p>
First, the blood level of 25-Hydroxy vitamin D [25(OH)D] was measured in all the patients. One group received oral vitamin D (cholecalciferol), 50000 units per week for 12 weeks, while the other group received placebo for the same period of time. In all patients, fasting blood sugar (FBS), blood sugar (BS), 2 hour postprandial blood sugar (2-hpp) and HbA1c were measured before and after drug therapy. Serum 25(OH)D was measured with ELISA method with sensitivity of 5 nol/L (2 ng/ml) and specificity of 100 percent by Stat fax 2100 produced by Awareness Company (The United States). Serum 25(OH)D of below 50 nmol/L was considered deficient, between 50 and 70 nmol/L insufficient, between 75 and 250 nmol/L sufficient and over 250 nmol/L potential intoxication. HbA1c was measured using column chromatography method with Nyco card reader II made in Norway. FBS, 2-hpp, BS were measured using spectrophotometer by Erba-XL 300 made in Germany.
</p></sec><sec id="s3-3"><title>
Ethical issues
</title><p>
The research followed the tenets of the Declaration of Helsinki. Written informed consent was obtained from all patients. This study was approved by Ethical Committee of Shahrekord University of Medical Science. This study was registered in Iranian Registry of Clinical Trials (IRCT) and achieved the code of IRCT201011185191N6, too.
</p></sec><sec id="s3-4"><title>
Statistical analysis
</title><p>
The data was analyzed with Stata software version 12 (Stata Corp, College Station, Tex) using student t-test, paired t-test, Pearson correlation and Chi square tests. P values of less than 0.05 was assumed to be significant (p&#x0003c;0.05).
</p></sec></sec><sec id="s4"><title>
Results
</title><p>
A total number of 60 type 2 diabetic patients were randomly assigned into two groups of intervention and control, each group consisting of 30 patients. The intervention group received vitamin D and the control group received placebo. The age of the patients ranged from 34 to 76 with the mean (SD) age of 55 (10.7) years. There was not significant difference of age between groups (p= 0.88). Seventeen patients (28.3%) were male. The female to male ratio was not statistically significant (p= 0.58). Five patients had vitamin D deficiency (8.3%), 27 (45%) had insufficient levels of vitamin D and in 28 (45%) patients vitamin D levels were within normal limits. None of the patients had vitamin D intoxication. There was no significant relation between HbA1c and 25(OH)D level prior the study (p=0.379). <xref ref-type="table" rid="T1">Table 1 </xref> demonstrates the laboratory parameters of both groups before and after the intervention. After intervention, 25 (OH)D level in interventional group was significantly higher compared to that of control group. HbA1c serum value of male diabetic patients in interventional group was less than that of control group (p=0.0068).
</p><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><title>
Mean (SD) of HbA1C and 25(OH)D and other laboratory parameters in relation to sex
</title></caption><table frame="hsides" rules="none"><tbody><tr style="border-width: 0px 0px 1pt 0px ; border-style: none none solid none"><td rowspan="2" colspan="1">
<bold>Time of measurement</bold>
<break/>
<bold>Group</bold>
</td><td colspan="3" align="center" rowspan="1">
<bold>Intervention Group</bold>
</td><td colspan="3" align="center" rowspan="1">
<bold>Control Group</bold>
</td><td colspan="2" align="center" rowspan="1">
<bold>Comparison Between Group P value*</bold>
</td></tr><tr style="border-width: 0px 0px 1pt 0px ; border-style: none none solid none"><td rowspan="1" colspan="1">
before<break/>Mean (SD)
</td><td rowspan="1" colspan="1">
after<break/>Mean (SD)
</td><td rowspan="1" colspan="1">P value</td><td rowspan="1" colspan="1">
before<break/>Mean (SD)
</td><td rowspan="1" colspan="1">
after<break/>Mean (SD)
</td><td rowspan="1" colspan="1">P value</td><td rowspan="1" colspan="1">Interventional</td><td rowspan="1" colspan="1">Control</td></tr><tr style="background-color:#dce6f2"><td rowspan="3" colspan="1">
HbA1c
</td><td rowspan="1" colspan="1">Male</td><td rowspan="1" colspan="1">7.67 (0.5)</td><td rowspan="1" colspan="1">6.78 (0.9)</td><td rowspan="1" colspan="1">0.0068*</td><td rowspan="1" colspan="1">7.41 (0.4)</td><td rowspan="1" colspan="1">6.97 (0.7)</td><td rowspan="1" colspan="1">0.22</td><td rowspan="1" colspan="1">0.019*</td><td rowspan="1" colspan="1">0.214</td></tr><tr style="background-color:#dce6f2"><td rowspan="1" colspan="1">Female</td><td rowspan="1" colspan="1">7.65 (0.4)</td><td rowspan="1" colspan="1">7.45 (1.3)</td><td rowspan="1" colspan="1">0.52</td><td rowspan="1" colspan="1">7.68 (0.5)</td><td rowspan="1" colspan="1">7.67 (1)</td><td rowspan="1" colspan="1">0.95</td><td rowspan="1" colspan="1">0.53</td><td rowspan="1" colspan="1">0.959</td></tr><tr style="background-color:#dce6f2"><td rowspan="1" colspan="1">Total</td><td rowspan="1" colspan="1">7.65 (0.4)</td><td rowspan="1" colspan="1">7.62 (0.52)</td><td rowspan="1" colspan="1">0.799</td><td rowspan="1" colspan="1">7.22 (1.2)</td><td rowspan="1" colspan="1">7.51 (1)</td><td rowspan="1" colspan="1">0.349</td><td rowspan="1" colspan="1">0.071</td><td rowspan="1" colspan="1">0.551</td></tr><tr><td rowspan="3" colspan="1">25(OH)D (nmol/L)</td><td rowspan="1" colspan="1">Male</td><td rowspan="1" colspan="1">82.5 (49)</td><td rowspan="1" colspan="1">167.8 (32)</td><td rowspan="1" colspan="1">0.001*</td><td rowspan="1" colspan="1">93.3 (67)</td><td rowspan="1" colspan="1">94.5 (55)</td><td rowspan="1" colspan="1">0.83</td><td rowspan="1" colspan="1">0.002*</td><td rowspan="1" colspan="1">0.971</td></tr><tr><td rowspan="1" colspan="1">Female</td><td rowspan="1" colspan="1">84.6 (54)</td><td rowspan="1" colspan="1">162.2 (67)</td><td rowspan="1" colspan="1">0.001*</td><td rowspan="1" colspan="1">109.5 (64)</td><td rowspan="1" colspan="1">122.2 (103)</td><td rowspan="1" colspan="1">0.4</td><td rowspan="1" colspan="1">0.003*</td><td rowspan="1" colspan="1">0.619</td></tr><tr><td rowspan="1" colspan="1">Total</td><td rowspan="1" colspan="1">83.9 (52)</td><td rowspan="1" colspan="1">164 (57)</td><td rowspan="1" colspan="1">0.001*</td><td rowspan="1" colspan="1">105.7 (64)</td><td rowspan="1" colspan="1">115.8 (94)</td><td rowspan="1" colspan="1">0.39</td><td rowspan="1" colspan="1">0.001*</td><td rowspan="1" colspan="1">0.632</td></tr></tbody></table><table-wrap-foot><fn><p>*P &#x0003c;0.05 comparing the data of each group before and after intervention</p></fn></table-wrap-foot></table-wrap></sec><sec id="s5"><title>
Discussion
</title><p>
In this study, we found that serum HbA1c value was significantly less than that of control group in male interventional group. It means that, vitamin D therapy has had beneficial effect on the control of blood sugar in male diabetic patients. Vitamin D has evolved widespread interest in the pathogenesis and prevention of diabetes. Various prospective cohort investigations have shown that serum vitamin D level is inversely related to risk of T2DM (<xref rid="R18" ref-type="bibr">18</xref>).<bold/>Sadek <italic>et al</italic>. conducted a study to evaluate the potential therapeutic efficacy of Vitamin D in preventing the detrimental effects of both types of diabetes mellitus, on 50 male Wistar rats. They found that, Vitamin D improved the deleterious biochemical impact of diabetes mellitus, likely by increasing insulin secretion and sensitivity, improving the &#x003b2;-cell function, and decreasing the number of pro-inflammatory cytokines and insulin resistance (<xref rid="R19" ref-type="bibr">19</xref>). Altered expression of glucose transporters is a major characteristic of diabetes (<xref rid="R12" ref-type="bibr">12</xref>-<xref rid="R16" ref-type="bibr">16</xref>). Tamilselvan <italic>et al.,</italic> aimed to investigate the effect of vitamin D in the overall regulation of muscle cell glucose transporter expression. Treatment of myoblasts with 10-7 M calcitriol for 24 h showed a significant increase in glucose transporter type 1 (GLUT1), GLUT4, vitamin D receptor (VDR), and insulin receptor expression in type 1 and 2 diabetic model compared to control group. The results showed a potential anti-diabetic function of vitamin D on GLUT4, VDR, GLUT1 and insulin receptor by improving receptor gene expression suggesting a role for vitamin D in regulation of expression of the glucose transporters in muscle cells (<xref rid="R20" ref-type="bibr">20</xref>). To assess the relationship between 25 (OH) vitamin D level and microvascular complications in patients with T2DM, 136 patients were enrolled in the cross-sectional study of Ahmadieh <italic>et al.</italic> They found, serum 25 (OH) vitamin D correlated negatively with HbA1c. They concluded that, low 25 (OH) vitamin D level was an independent predictor of HbA1c, diabetic neuropathy, and diabetic retinopathy in patients with T2DM (<xref rid="R21" ref-type="bibr">21</xref>). However, Tai <italic>et al.</italic> found that in short term, correcting of vitamin D level had no significant impact on blood glucose level, plasma insulin, insulin sensitivity or oral glucose tolerance test in vitamin D deficient patients who had not diabetes (<xref rid="R10" ref-type="bibr">10</xref>). Iyengar <italic>et al.</italic> measured fasting blood glucose level, C peptide and insulin as well as 2 hours blood sugar after 75 gram oral glucose intake in a Hispanic-American and Angolan population in order to assess the role of vitamin D binding globulin on regulating blood glucose level. The study showed a significant positive correlation between fasting blood sugar and vitamin D binding peptide genotype (<xref rid="R22" ref-type="bibr">22</xref>). Hossein-Nezhad <italic>et al.</italic> evaluated 741 pregnant women in a cross-sectional survey. They found, a significant association between insulin resistance index and insulin sensitivity index with serum vitamin D level (after adjusting for BMI) (<xref rid="R23" ref-type="bibr">23</xref>). Additionally, active form of vitamin D is a protective factor against type 1 diabetic none-obese rats, which was found in the study of Giulietti <italic>et al</italic>. They also showed that incidence of type1 DM was higher in none-obese rats which were exposed to vitamin D deficiency in their early life (<xref rid="R24" ref-type="bibr">24</xref>). Likewise, Champe <italic>et al.</italic> found a negative association between serum vitamin D levels and fasting blood glucose and postprandial glucose levels too (<xref rid="R25" ref-type="bibr">25</xref>). As seen above, most researches indicating the impact of serum vitamin D level and blood glucose and insulin resistance are either experimental or cross-sectional epidemiologic studies or on non-diabetic patients.
</p></sec><sec id="s6"><title>
Conclusion
</title><p>
In our study, on 60 type 2 diabetes patients, who were randomly assigned into two equal groups of intervention and control, we found that weekly vitamin D supplementation (50000 units for 12 weeks) had beneficial effect on HbA1c of male type 2 diabetes mellitus patients. However studies with larger sample size and longer duration of intervention or higher dosage of vitamin D supplements suggests.
</p></sec><sec id="s7"><title>
Authors&#x02019; contributions
</title><p>
Main draft write up and editing by SB, PN, HN and ARM. Important intellectual content and critical revision by MRK and AA.
</p></sec><sec id="s8"><title>
Conflict of interests
</title><p>
The author declared no competing interests.
</p></sec><sec id="s9"><title>
Ethical consideration
</title><p>
Ethical issues (including plagiarism, misconduct, data fabrication, informed consent, double publication) have been completely observed by the authors.
</p></sec><sec id="s10"><title>
Funding/Support
</title><p>
This paper has been derived from the residential thesis. This study was granted by Shahrekord University of Medical Sciences (Grant# 844).
</p></sec></body><back><ref-list><title>References</title><ref id="R01"><label>1</label><element-citation publication-type="journal"><name><surname>Fu</surname><given-names>J</given-names></name><name><surname>Prasad</surname><given-names>HC</given-names></name><article-title>Changing epidemiology of metabolic syndrome and type 2 diabetes in chinese youth</article-title><source>Curr Diab Rep</source><year>2014</year><volume>14</volume><fpage>447</fpage><pub-id pub-id-type="pmid">24277673</pub-id></element-citation></ref><ref id="R02"><label>2</label><element-citation publication-type="journal"><name><surname>Baradaran</surname><given-names>A</given-names></name><name><surname>Behradmanesh</surname><given-names>S</given-names></name><name><surname>Nasri</surname><given-names>H</given-names></name><article-title>Association of body mass index and serum vitamin D level in healthy Iranian adolescents</article-title><source>Endokrynol Pol</source><year>2012</year><volume>63</volume><fpage>29</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">22378095</pub-id></element-citation></ref><ref id="R03"><label>3</label><element-citation publication-type="journal"><name><surname>Takeda</surname><given-names>E</given-names></name><name><surname>Yamamoto</surname><given-names>H</given-names></name><name><surname>Taketani</surname><given-names>Y</given-names></name><name><surname>Miyamoto</surname><given-names>K</given-names></name><article-title>Vitamin D-dependent rickets type I and type II</article-title><source>Acta Paediatr Jpn</source><year>1997</year><volume>39</volume><fpage>508</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">9316302</pub-id></element-citation></ref><ref id="R04"><label>4</label><element-citation publication-type="journal"><name><surname>Harris</surname><given-names>SS</given-names></name><name><surname>Dawson-Hughes</surname><given-names>B</given-names></name><article-title>Seasonal changes in plasma 25-hydroxyvitamin D concentrations of young American black and white women</article-title><source>Am J Clin Nutr</source><year>1998</year><volume>67</volume><fpage>1232</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">9625098</pub-id></element-citation></ref><ref id="R05"><label>5</label><element-citation publication-type="journal"><name><surname>Borissova</surname><given-names>AM</given-names></name><name><surname>Tankova</surname><given-names>T</given-names></name><name><surname>Kirilov</surname><given-names>G</given-names></name><name><surname>Dakovska</surname><given-names>L</given-names></name><name><surname>Kovacheva</surname><given-names>R</given-names></name><article-title>The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients</article-title><source>Int J Clin Pract</source><year>2003</year><volume>57</volume><fpage>258</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">12800453</pub-id></element-citation></ref><ref id="R06"><label>6</label><element-citation publication-type="journal"><name><surname>Gedik</surname><given-names>O</given-names></name><name><surname>Akalin</surname><given-names>S</given-names></name><article-title>Effects of vitamin D deficiency and repletion on insulin and glucagon secretion in man</article-title><source>Diabetologia</source><year>1986</year><volume>29</volume><fpage>142</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">3516771</pub-id></element-citation></ref><ref id="R07"><label>7</label><element-citation publication-type="journal"><name><surname>Forouhi</surname><given-names>NG</given-names></name><name><surname>Luan</surname><given-names>J</given-names></name><name><surname>Cooper</surname><given-names>A</given-names></name><name><surname>Boucher</surname><given-names>BJ</given-names></name><name><surname>Wareham</surname><given-names>NJ</given-names></name><article-title>Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000</article-title><source>Diabetes</source><year>2008</year><volume>57</volume><fpage>2619</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">18591391</pub-id></element-citation></ref><ref id="R08"><label>8</label><element-citation publication-type="journal"><name><surname>Chertow</surname><given-names>BS</given-names></name><name><surname>Sivitz</surname><given-names>WI</given-names></name><name><surname>Baranetsky</surname><given-names>NG</given-names></name><name><surname>Cordle</surname><given-names>MB</given-names></name><name><surname>DeLuca</surname><given-names>HF</given-names></name><article-title>Islet insulin release and net calcium retention in vitro in vitamin D-deficient rats</article-title><source>Diabetes</source><year>1986</year><volume>35</volume><fpage>771</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">3522318</pub-id></element-citation></ref><ref id="R09"><label>9</label><element-citation publication-type="journal"><name><surname>Kumar</surname><given-names>S</given-names></name><name><surname>Davies</surname><given-names>M</given-names></name><name><surname>Zakaria</surname><given-names>Y</given-names></name><name><surname>Mawer</surname><given-names>EB</given-names></name><name><surname>Gordon</surname><given-names>C</given-names></name><name><surname>Olukoga</surname><given-names>AO</given-names></name><etal/><article-title>Improvement in glucose tolerance and beta-cell function in a patient with vitamin D deficiency during treatment with vitamin D</article-title><source>Postgrad Med J</source><year>1994</year><volume>70</volume><fpage>440</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">8029165</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><name><surname>Tai</surname><given-names>K</given-names></name><name><surname>Need</surname><given-names>AG</given-names></name><name><surname>Horowitz</surname><given-names>M</given-names></name><name><surname>Chapman</surname><given-names>IM</given-names></name><article-title>Glucose tolerance and vitamin D: effects of treating vitamin D deficiency</article-title><source>Nutrition</source><year>2008</year><volume>24</volume><fpage>950</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">18653316</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><name><surname>Danescu</surname><given-names>LG</given-names></name><name><surname>Levy</surname><given-names>S</given-names></name><name><surname>Levy</surname><given-names>J</given-names></name><article-title>Vitamin D and diabetes mellitus</article-title><source>Endocrine</source><year>2009</year><volume>35</volume><fpage>11</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">18979202</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><name><surname>Chertow</surname><given-names>BS</given-names></name><name><surname>Sivitz</surname><given-names>WI</given-names></name><name><surname>Baranetsky</surname><given-names>NG</given-names></name><name><surname>Cordle</surname><given-names>MB</given-names></name><name><surname>DeLuca</surname><given-names>HF</given-names></name><article-title>Islet insulin release and net calcium retention in vitro in vitamin D-deficient rats</article-title><source>Diabetes</source><year>1986</year><volume>35</volume><fpage>771</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">3522318</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><name><surname>Kumar</surname><given-names>S</given-names></name><name><surname>Davies</surname><given-names>M</given-names></name><name><surname>Zakaria</surname><given-names>Y</given-names></name><name><surname>Mawer</surname><given-names>EB</given-names></name><name><surname>Gordon</surname><given-names>C</given-names></name><name><surname>Olukoga</surname><given-names>AO</given-names></name><etal/><article-title>Improvement in glucose tolerance and beta-cell function in a patient with vitamin D deficiency during treatment with vitamin D</article-title><source>Postgrad Med J</source><year>1994</year><volume>70</volume><fpage>440</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">8029165</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><name><surname>Verges</surname><given-names>B</given-names></name><article-title>New insight into the pathophysiology of lipid abnormalities in type 2 diabetes</article-title><source>Diabetes Metab</source><year>2005</year><volume>31</volume><fpage>429</fpage><lpage>39</lpage><pub-id pub-id-type="pmid">16357786</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><name><surname>Rosen</surname><given-names>CJ</given-names></name><article-title>Rosen CJClinical practiceVitamin D insufficiency</article-title><source>N Engl J Med</source><year>2011</year><volume>364</volume><fpage>248</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">21247315</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><name><surname>Iyengar</surname><given-names>S</given-names></name><name><surname>Hamman</surname><given-names>RF</given-names></name><name><surname>Marshall</surname><given-names>JA</given-names></name><name><surname>Majumder</surname><given-names>PP</given-names></name><name><surname>Ferrell</surname><given-names>RE</given-names></name><article-title>On the role of vitamin D binding globulin in glucose homeostasis: results from the San Luis Valley Diabetes Study</article-title><source>Genet Epidemiol</source><year>1989</year><volume>6</volume><fpage>691</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">2691326</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><name><surname>Walter</surname><given-names>M</given-names></name><name><surname>Kaupper</surname><given-names>T</given-names></name><name><surname>Adler</surname><given-names>K</given-names></name><name><surname>Foersch</surname><given-names>J</given-names></name><name><surname>Bonifacio</surname><given-names>E</given-names></name><name><surname>Ziegler</surname><given-names>AG</given-names></name><article-title>No effect of the 1alpha,25-dihydroxyvitamin D3 on beta-cell residual function and insulin requirement in adults with new-onset type 1 diabetes</article-title><source>Diabetes Care</source><year>2010</year><volume>33</volume><fpage>1443</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">20357369</pub-id></element-citation></ref><ref id="R18"><label>18</label><mixed-citation publication-type="other">
Abbas S, Linseisen J, Rohrmann S, Beulens JW, Buijsse B, Amiano P, et al. Dietary vitamin D intake and risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition: the EPIC-InterAct study. Eur J Clin Nutr 2013; forthcoming.
</mixed-citation></ref><ref id="R19"><label>19</label><mixed-citation publication-type="other">
Sadek KM, Shaheen H. Biochemical efficacy of vitamin D in ameliorating endocrine and metabolic disorders in diabetic rats. Pharm Biol 2013; forthcoming.
</mixed-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><name><surname>Tamilselvan</surname><given-names>B</given-names></name><name><surname>Seshadri</surname><given-names>KG</given-names></name><name><surname>Venkatraman</surname><given-names>G</given-names></name><article-title>Role of vitamin D on the expression of glucose transporters in L6 myotubes</article-title><source>Indian J Endocrinol Metab</source><year>2013</year><volume>17</volume><fpage>S326</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">24251203</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><name><surname>Ahmadieh</surname><given-names>H</given-names></name><name><surname>Azar</surname><given-names>ST</given-names></name><name><surname>Lakkis</surname><given-names>N</given-names></name><name><surname>Arabi</surname><given-names>A</given-names></name><article-title>Hypovitaminosis d in patients with type 2 diabetes mellitus: a relation to disease control and complications</article-title><source>SRN Endocrinol</source><year>2013</year><volume>2013</volume><fpage>641098</fpage></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><name><surname>Iyengar</surname><given-names>S</given-names></name><name><surname>Hamman</surname><given-names>RF</given-names></name><name><surname>Marshall</surname><given-names>JA</given-names></name><name><surname>Majumder</surname><given-names>PP</given-names></name><name><surname>Ferrell</surname><given-names>RE</given-names></name><article-title>On the role of vitamin D binding globulin in glucose homeostasis: results from the San Luis Valley Diabetes Study</article-title><source>Genet Epidemiol</source><year>1989</year><volume>6</volume><fpage>691</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">2691326</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><name><surname>Hossein-Nezhad</surname><given-names>A</given-names></name><name><surname>Maghbooli</surname><given-names>J</given-names></name><name><surname>Arzaghi</surname><given-names>SM</given-names></name><name><surname>Shafaei1</surname><given-names>A</given-names></name><name><surname>Rahmani1</surname><given-names>M</given-names></name><name><surname>Larijani</surname><given-names>B</given-names></name><article-title>Relationship between vitamin D Deficiency and gestational diabetes mellitus</article-title><source>J Diabetes Metab Disord</source><year>2006</year><volume>5</volume><fpage>226</fpage><lpage>35</lpage></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><name><surname>Giulietti</surname><given-names>A</given-names></name><name><surname>Gysemans</surname><given-names>C</given-names></name><name><surname>Stoffels</surname><given-names>K</given-names></name><name><surname>van</surname><given-names>EE</given-names></name><name><surname>Decallonne</surname><given-names>B</given-names></name><name><surname>Overbergh</surname><given-names>L</given-names></name><etal/><article-title>Vitamin D deficiency in early life accelerates Type 1 diabetes in non-obese diabetic mice</article-title><source>Diabetologia</source><year>2004</year><volume>47</volume><fpage>451</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">14758446</pub-id></element-citation></ref><ref id="R25"><label>25</label><mixed-citation publication-type="other">
Champe PC, Harvey RA, Ferrier DR. Biochemitry. 4<sup>th</sup> ed. Philadelphia: Lippincott, Williams and Willkins; 2009. p. 510.
</mixed-citation></ref></ref-list></back></article>